These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22198442)

  • 1. All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study.
    Tenback D; Pijl B; Smeets H; Os Jv; Harten Pv
    J Clin Psychopharmacol; 2012 Feb; 32(1):31-5. PubMed ID: 22198442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.
    Baandrup L; Gasse C; Jensen VD; Glenthoj BY; Nordentoft M; Lublin H; Fink-Jensen A; Lindhardt A; Mortensen PB
    J Clin Psychiatry; 2010 Feb; 71(2):103-8. PubMed ID: 19895781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
    Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
    J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
    Ward A; Ishak K; Proskorovsky I; Caro J
    Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and its determinants in people with psychotic disorder.
    Suvisaari J; Partti K; Perälä J; Viertiö S; Saarni SE; Lönnqvist J; Saarni SI; Härkänen T
    Psychosom Med; 2013 Jan; 75(1):60-7. PubMed ID: 23257931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious cardiovascular events and mortality among patients with schizophrenia.
    Enger C; Weatherby L; Reynolds RF; Glasser DB; Walker AM
    J Nerv Ment Dis; 2004 Jan; 192(1):19-27. PubMed ID: 14718772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
    Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
    Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
    Mehta S; Johnson ML; Chen H; Aparasu RR
    J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somnolence effects of antipsychotic medications and the risk of unintentional injury.
    Said Q; Gutterman EM; Kim MS; Firth SD; Whitehead R; Brixner D
    Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):354-64. PubMed ID: 18314925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study.
    Brnabic AJ; Kelin K; Ascher-Svanum H; Montgomery W; Kadziola Z; Karagianis J
    Int J Clin Pract; 2011 Sep; 65(9):945-53. PubMed ID: 21849009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
    Wang PS; Schneeweiss S; Avorn J; Fischer MA; Mogun H; Solomon DH; Brookhart MA
    N Engl J Med; 2005 Dec; 353(22):2335-41. PubMed ID: 16319382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mortality among chronic schizophrenic patients: a prospective 14-year follow-up study of 150 schizophrenic patients].
    Loas G; Azi A; Noisette C; Yon V
    Encephale; 2008 Jan; 34(1):54-60. PubMed ID: 18514151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events in elderly users of antipsychotic pharmacotherapy in the province of Manitoba: a retrospective cohort study.
    Vasilyeva I; Biscontri RG; Enns MW; Metge CJ; Alessi-Severini S
    J Clin Psychopharmacol; 2013 Feb; 33(1):24-30. PubMed ID: 23277238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia.
    Stroup TS; Gerhard T; Crystal S; Huang C; Tan Z; Wall MM; Mathai C; Olfson M
    JAMA Psychiatry; 2019 May; 76(5):508-515. PubMed ID: 30785609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications.
    Setoguchi S; Wang PS; Alan Brookhart M; Canning CF; Kaci L; Schneeweiss S
    J Am Geriatr Soc; 2008 Sep; 56(9):1644-50. PubMed ID: 18691283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).
    Thomas SH; Drici MD; Hall GC; Crocq MA; Everitt B; Lader MH; Le Jeunne C; Naber D; Priori S; Sturkenboom M; Thibaut F; Peuskens J; Mittoux A; Tanghøj P; Toumi M; Moore ND; Mann RD
    Acta Psychiatr Scand; 2010 Nov; 122(5):345-55. PubMed ID: 20384598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.